Patient Perspective: A conversation with Philip Yeske, PhD – Science & Alliance Officer, UMDF

find more articles

Khondrion Strengthens Governance with Appointment of Experienced Supervisory Board

Khondrion Appoints Jasper Levink as New CEO to Lead Next Phase of Growth

Khondrion and Medvisis Announce Exclusive Licensing Agreement to Commercialize Sonlicromanol for Primary Mitochondrial Diseases in Switzerland and Liechtenstein

view all articles